Division of Neurocritical Care, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Division of Neurocritical Care and Emergency Neurology, Yale New Haven Hospital, New Haven, CT, USA.
Neurocrit Care. 2022 Feb;36(1):46-51. doi: 10.1007/s12028-021-01341-x. Epub 2021 Sep 7.
Cerebral edema is associated with worse outcome after acute stroke; however, the minimum clinically relevant threshold remains unknown. This study aimed to identify the minimal degree of midline shift (MLS) that predicts outcome in a cohort encompassing a broad range of patients with acute stroke.
Patient-level data from six acute stroke clinical trials were combined with endovascular thrombectomy registries from two academic referral centers, generating a combined cohort of 1977 patients. MLS was extracted from the original trial data or measured on computed tomography or magnetic resonance imaging that was obtained a median of 47.0 h (interquartile range 27.0-75.1 h) after stroke onset. Logistic regression was performed to identify predictors of poor outcome and the minimal clinically relevant MLS threshold.
The presence of MLS was a predictor of poor outcome, independent of baseline clinical and demographic factors (adjusted odds ratio 4.46, 95% confidence interval 3.56-5.59, p < 0.001). Examining the full range of MLS values identified, a value of greater than 3 mm was the critical threshold that significantly predicted poor outcome (adjusted odds ratio 3.20 [1.31-7.82], p = 0.011).
These results show that the presence of MLS predicts poor outcome and, specifically, MLS value greater than 3 mm is an important threshold across a variety of clinical settings. These findings may have relevance for the design and interpretation of future trials for antiedema therapies.
脑水肿与急性脑卒中后预后不良相关;然而,其最小临床相关阈值仍不清楚。本研究旨在确定中线移位(MLS)的最小程度,以预测涵盖广泛急性脑卒中患者队列的结局。
来自六项急性脑卒中临床试验的患者水平数据与来自两个学术转诊中心的血管内血栓切除术登记处合并,产生了包括 1977 例患者的合并队列。从原始试验数据中提取 MLS,或在脑卒中发病后中位数 47.0 h(27.0-75.1 h)时获得的计算机断层扫描或磁共振成像上测量 MLS。使用逻辑回归来识别不良结局的预测因素和最小临床相关 MLS 阈值。
MLS 的存在是不良结局的预测因素,独立于基线临床和人口统计学因素(调整后的优势比 4.46,95%置信区间 3.56-5.59,p < 0.001)。在检查了所确定的整个 MLS 值范围后,大于 3 mm 的 MLS 值是显著预测不良结局的临界阈值(调整后的优势比 3.20 [1.31-7.82],p = 0.011)。
这些结果表明 MLS 的存在可预测不良结局,并且 MLS 值大于 3 mm 具体是各种临床环境中的重要阈值。这些发现可能与抗脑水肿治疗的未来试验的设计和解释有关。